Participants must complete an evaluation to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Medical Rehabilitation Providers Association (AMPRA). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement - Amedco designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Amedco is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This course is co-provided by Amedco and AMRPA. Maximum of 1.0 contact hour.
All CME activities must adhere to the ACCME’s content validation requirements. If/when any specific recommendations involving clinical medicine in a CME activity are made, they must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. In addition, all CME presentations must avoid commercial bias. All presenters must use the required disclosure slide that names any financial relationships or discussion of unlabeled/investigational uses of a medicine or device.
Health Care Executives: AMRPA is authorized to award 1.0 hours of pre-approved ACHE Qualified Education credit for this program toward advancement, or recertification, in the American College of Healthcare Executives. Participants in this program who wish to have the continuing education hours applied toward ACHE Qualified Education credit must self-report their participation. To self-report, participants must log into their MyACHE account and select “My Education Credit” to log hours earned.
The American Occupational Therapy Association, Inc.: This webinar has been approved for 0.1 AOTA CEU. (1 contact hour)The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. AMRPA is approved AOTA Provider #6595.
AOTA Classification Code: Category 3 Professional Issues
As part of the American Occupational Therapy Association’s (AOTA) Approved Provider renewal process, AOTA is requesting that participants of this course complete a short online survey about your continuing education experience with our organization as an AOTA Approved Provider.
Completing this survey will also enter you into a quarterly drawing for a $100 voucher
for AOTA publications or CE. To access the survey go to http://www.aota.org/appsurvey.
ASHA CE Statement
Effective 06/05/17, AMRPA will no longer be an ASHA CEU Provider. Members will no longer be able to submit their CEU’s to ASHA for their approval of our programs, but will still earn Continuing Education credits for all AMRPA Educational activities. You will claim your CEU’s and receive a Certificate through AMRPA as you always have. AMRPA’s Educational activities are accepted by most state licensing boards.Please check your state’s licensing rules.
Objectives - After attending this program you should be able to:
- Describe recent updates and changes to IRF quality measures and the IRF QRP.
- Explain how the IRF QRP could impact your hospital in the future.
- Discuss the context of quality reporting within current policy frameworks.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.